Form 4: IN8BIO Director Alan S. Roemer Acquires Stock Options

Director Alan S. Roemer acquired stock options in IN8BIO, INC. on June 12, 2024.

Summary

• On June 12, 2024, Alan S. Roemer, a director of IN8BIO, INC., acquired stock options.
• The stock options grant the right to buy 33,650 shares of common stock at an exercise price of $1.47.
• The options vest in equal monthly installments starting July 12, 2024, and will be fully vested by the date of the company's next annual meeting of stockholders, contingent upon continued service.
• The options expire on June 12, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director. While option grants can be seen as a positive incentive, this is a routine filing.

Positives

• The acquisition of stock options by a director may signal confidence in the company's future performance.

Future Outlook

The vesting schedule is contingent upon the Reporting Person continuing to provide service through each vesting date, implying an expectation of continued involvement with the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation.

Stakeholder Impact

• The acquisition of stock options by a director can be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates